The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens

Autor: Prajeeth, CK, Jirmo, AC, Krishnaswamy, JK, Ebensen, T, Guzman, CA, Weiss, S, Constabel, H, Schmidt, RE, Behrens, GM
Jazyk: angličtina
Rok vydání: 2010
Předmět:
DOI: 10.3205/10kit001
Popis: The property of dendritic cells (DC) to generate effective cytotoxic T lymphocyte (CTL) responses is influenced by Toll-like Receptor (TLR) signalling. TLR ligands contain molecular signatures associated with pathogens, are being exploited as potential adjuvants, and have impact on the antigen processing[for full text, please go to the a.m. URL]
10. Kongress für Infektionskrankheiten und Tropenmedizin (KIT 2010)
Databáze: OpenAIRE